The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Transaction #25824 · Form 4 · 0001753926-25-001991

Pelthos Therapeutics Inc. · Stock award · Common Stock

Pelthos Therapeutics Inc. · Transacted December 23, 2025 · Filed December 29, 2025

Original SEC filing ↗

What does this filing report?

An SEC Form 4 filing for Pelthos Therapeutics Inc. records a stock award involving Common Stock on December 23, 2025. The reported quantity was 12,000. The filing date is December 29, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.

The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.

Transaction details

Company CIK
0001919246
Security type
Non-derivative
Acquisition type
Stock award · Code A
Quantity acquired
12,000
Reported price
Not reported · See footnotes
Reference value
Not reported
Currency
Currency not specified
Ownership
Direct
Holdings after transaction
12,000
Ownership description
Not reported
SEC acceptance time
Dec 29, 2025, 4:16 PM EST
10b5-1 indication
Not indicated

Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.

Reporting owners

These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.

Company listings

PTHS · NYSE · linked security

The linked listing is identified separately from other current company listings.

Filing footnotes & remarks

F1
On December 23, 2025, the Reporting Person was granted 12,000 Restricted Stock Units (the "RSUs") of the issuer, as compensation for the Reporting Person's service as a member of the issuer's board of directors, pursuant to the issuer's 2023 Equity Incentive Plan, as amended and restated effective as of April 16, 2025 (the "Plan"). The RSUs will vest on January 1, 2027. Each RSU represents a contingent right to receive one share of issuer's Common Stock, par value $0.0001 per share.

Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.

This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.